(Press-News.org) Scientists at the National Center for Supercomputing Applications and the University of Illinois College of Medicine Peoria (UICOMP) were authors of a research paper published in the Journal of Acoustical Society of America Express Letters that demonstrates improved, automated screening methods for anxiety and major depressive disorders.
In the project titled, “Automated acoustic voice screening techniques for comorbid depression and anxiety disorders,” Mary Pietrowicz, along with colleagues from the University of Illinois Urbana-Champaign and UICOMP, explored how machine learning could effectively distinguish individuals with comorbid depression and anxiety disorders from healthy controls using acoustic and phonemic analysis of semantic verbal fluency data.
More and more people are being diagnosed with these disorders, yet many suffering remain undiagnosed due to known perceptual, attitudinal and structural barriers. Anxiety affects 19.1% of adults in the United States and major depression 8.3% while being the leading cause of disability in individuals under 40 years old. Despite this high prevalence, treatment rates are low and, if left untreated, can lead to decreased productivity, poor functioning in society, erosion of cognitive abilities, strained relationships and suicide.
New methods, tools and technologies – such as automated acoustic voice analysis – are needed to overcome these barriers and improve screening rates.
This research demonstrates that analysis of short samples of acoustic voice, specifically one-minute verbal fluency tests, can be used in screening for anxiety and depression disorders, and can function online, at any time, addressing many of the barriers to screening and treatment. In addition, our AI models provide explainability, and therefore insight, into the impact that depression and anxiety have on speech and language. This work enables the development of clinical screening and tracking systems at scale.
Mary Pietrowicz, NCSA Senior Research Scientist
Researchers tested a custom dataset curated specifically for this study that included both healthy people and people with comorbid depression and anxiety across the spectrum of severity. People with other comorbid conditions known to affect speech and language were excluded from the study. Acoustic models using only data from one-minute verbal fluency tests discerned the presence of comorbid disorders at a highly successful rate.
“The data for this study were collected by multiple medical students at the University of Illinois College of Medicine Peoria,” said UICOMP Director of Research Services Sarah Donohue. “These students interviewed each of the participants, recorded the interviews and did an animal naming task at the end of the interviews with the participants.”
A primary benefit of these acoustic tests is that they’re accessible. They may be administered either online, in-app or in-clinic, which directly addresses known barriers to screening, including factors such as stigma, low self-perception of need, costs, transportation issues and limited access to healthcare.
“The development of an efficient, accurate and easy-to-use method for screening patients who may be suffering from depression or anxiety offers tremendous promise,” said UICOMP Chair and Professor of Clinical Psychiatry Ryan Finkenbine. “The application of advanced machine learning models to the clinical setting provides a remarkable path for clinicians to screen for signs of mental illness in an adaptive and practical way. Patients and clinicians alike will benefit from improved methods for comprehensive medical and mental health care.”
ABOUT NCSA
The National Center for Supercomputing Applications at the University of Illinois Urbana-Champaign provides supercomputing, expertise and advanced digital resources for the nation’s science enterprise. At NCSA, University of Illinois faculty, staff, students and collaborators from around the globe use innovative resources to address research challenges for the benefit of science and society. NCSA has been assisting many of the world’s industry giants for over 35 years by bringing industry, researchers and students together to solve grand challenges at rapid speed and scale.
END
NCSA research offers new diagnostic tool for anxiety, major depressive disorder
2025-03-31
ELSE PRESS RELEASES FROM THIS DATE:
Single protein mimics retinoic acid therapy to help leukemia cells mature
2025-03-31
“This study reveals that the expression of the Src-family kinase (SFK), FGR, alone can induce cell differentiation similar to RA.”
BUFFALO, NY – March 31, 2025 – A new research paper was published in Oncotarget, Volume 16, on March 21, 2025, titled “FGR Src family kinase causes signaling and phenotypic shift mimicking retinoic acid-induced differentiation of leukemic cells.”
A research team led by first author Noor Kazim and corresponding author Andrew Yen from Cornell University discovered that the FGR protein—traditionally ...
Research: Top scientists issue urgent warning on fossil fuels
2025-03-31
WASHINGTON— In a review published today in the peer-reviewed journal Oxford Open Climate Change, top scientists issued an urgent warning that fossil fuels and the fossil fuel industry are driving interlinked crises that threaten people, wildlife, and a livable future.
Today’s review synthesizes the extensive scientific evidence showing that fossil fuels and the fossil fuel industry are fueling not only the climate crisis but also public health harms, environmental injustice, biodiversity loss, and the plastics ...
Thinner Arctic sea ice may affect the AMOC
2025-03-31
One of the ocean currents in the Arctic Ocean is at risk of disappearing this century because of climate change, according to a new joint study from the University of Gothenburg and the German Alfred Wegener Institute. As a result, the North Atlantic could be flooded with freshwater which would weaken the global ocean circulation.
The weakening of the AMOC, Atlantic Meridional Overturning Circulation, is a hot topic among the world's climate scientists. However, it is unclear what the consequences will be when ...
How dreams, novelty, and emotions can shape memories: lessons from smartphone studies
2025-03-31
BOSTON - March 31, 2025 - A memory is not a straight line from one point to another, even if we sometimes think of them like linear stories. This key insight that cognitive neuroscientists have known for many years is now guiding a new type of research—to explore not only how memories evolve over time but also how they can be strengthened or changed. Assisting researchers with this new exploration is a powerful tool: smartphones.
“Smartphones are an incredible tool for understanding patterns of feelings, behavior, ...
Leveraging Preexisting Cardiovascular Data to Improve the Detection and Treatment of Hypertension
2025-03-31
About The Study: In the NOTIFY-LVH randomized clinical trial, a centralized population health coordinator–led notification and clinical support pathway for individuals with left ventricular hypertrophy on prior echocardiograms increased the initial treatment of hypertension. This work highlights the potential benefit of leveraging preexisting but potentially underutilized cardiovascular data to improve health care delivery through mechanisms augmenting the traditional ambulatory care system.
Corresponding Author: To contact the corresponding author, Jason H. Wasfy, MD, MPhil, email jwasfy@mgh.harvard.edu.
To access the embargoed study: Visit ...
Study highlights barriers to including non-English speakers in research
2025-03-31
Health researchers omit including speakers of languages other than English (LOE) in their studies due to lack of training, challenges securing interpreter services, budget constraints and other barriers, according to a new JAMA Network Open study.
“Non-English-speaking individuals are being excluded from research, and we wanted to understand why,” said senior author Maya Ragavan, M.D., M.P.H., M.S., associate professor of pediatrics at the University of Pittsburgh. “Ensuring that everyone can participate in research, regardless of the languages that they speak, helps ensure that the findings are representative of the entire community, ...
Queen Mary launches new regenerative medicine spinout to repair joint damage and prevent arthritis
2025-03-31
The method is substantially cheaper and easier to administer than even the best of today’s approaches – making it significantly more viable for healthcare providers.
The invention paves the way for a future restorative treatment for osteoarthritis.
Scientists at Queen Mary University of London have invented a new way to repair osteochondral defects – a common form of joint damage often caused by sports injuries or trauma – and to prevent progression to osteoarthritis.
The treatment uses Agrin, the protein which builds and maintains the link between our motor neurons and muscle fibres. A small soluble polypeptide ...
Make these scientific sessions part of your media coverage
2025-03-31
New York, NY – March 31, 2025 – Register now for a complimentary media pass for the ATS 2025 International Conference in San Francisco. We will have breaking news from the leading international conference for pulmonary, critical care and sleep medicine.
See what scientific sessions we have planned:
Allergy/Immunology
Critical Care
Cellular/Molecular Biology
Bronchiectasis and COPD
Health Equity/Health Disparities
ILD
Pediatrics
Sleep
All registered media will receive a press release one week prior to the conference with ...
Common anticancer drugs may offer new hope to PTEN Hamartoma Tumour Syndrome patients
2025-03-31
During development, cells grow, expand, and migrate to generate tissues and organs in a highly controlled manner. Many intracellular pathways – series of signalling cascades within a cell – regulate these actions to avoid non-programmed growth that could lead to malformations or cancer. One of these pathways is the PTEN / PI3K axis, a complex series of perfectly balanced chemical reactions.
Mutations in the PTEN gene usually result in the overactivation of PI3K and the imbalance of the system. This may trigger the onset of different types ...
Boehringer Ingelheim and Lieber Institute for Brain Development advance development of COMT inhibitors to treat cognitive impairment in neuropsychiatric disorders
2025-03-31
Baltimore, Maryland (March 31, 2025) — The Lieber Institute for Brain Development, a nonprofit research institution dedicated to treating and preventing developmental brain disorders, today announced the progression toward clinical testing of a unique, centrally acting catechol Omethyltransferase (COMT) inhibitor from its collaboration with Boehringer Ingelheim.
COMT is a dopamine-metabolizing enzyme involved in the regulation of neurotransmitter levels. These are critical for cognitive and behavioral processes that are impaired in several neuropsychiatric disorders. While peripherally ...